TRVI
Trevi Therapeutics, Inc.
$13.77-0.50 (-3.50%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Trevi Therapeutics, Inc. (TRVI) is a publicly traded company with 5 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 5 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 18 transactions (past 365 days)
| 2026-02-20 | 2026-02-19 | Cassella James V | CDO | Award | 215,000 | $0.00 | $0 |
| 2026-02-20 | 2026-02-19 | Galletta Christopher | See Remarks | Award | 35,000 | $0.00 | $0 |
| 2026-02-20 | 2026-02-19 | Sciascia Thomas | CSO | Award | 85,000 | $0.00 | $0 |
| 2026-02-20 | 2026-02-19 | Good Jennifer L | CEO | Award | 675,000 | $0.00 | $0 |
| 2026-02-20 | 2026-02-19 | Simon Farrell | CCO | Award | 160,000 | $0.00 | $0 |
| 2026-01-12 | 2026-01-08 | Hastings David C | CFO | Award | 375,000 | $0.00 | $0 |
| 2025-12-03 | 2025-12-02 | Galletta Christopher | See Remarks | Exercise Conversion | 4,225 | $0.51 | $2,159 |
| 2025-12-03 | 2025-12-02 | Galletta Christopher | See Remarks | Exercise Conversion | 4,225 | $0.00 | $0 |
| 2025-06-13 | 2025-06-11 | Meeker David P | Director | Award | 45,000 | $0.00 | $0 |
| 2025-06-13 | 2025-06-11 | Colangelo Dominick | Director | Award | 45,000 | $0.00 | $0 |
TRVI
See Remarks
Exercise Conversion
$2.2K
Galletta Christopher4,225 shares @ $0.51
Filed 2025-12-03Trade 2025-12-02
TRVI
See Remarks
Exercise Conversion
$0
Galletta Christopher4,225 shares @ $0.00
Filed 2025-12-03Trade 2025-12-02
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.